NTRP NextTrip, Inc.
NextTrip, Inc. (NTRP) is expected to report earnings on October 14, 2026, during market hours. The consensus earnings estimate is a loss of $0.24 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -34.9% since its last earnings release on July 15, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About NextTrip, Inc.
Neurotrope Inc is a development stage company. The Company is a clinical stage biopharmaceutical and diagnostics company, engaged in developing drug candidate called bryostatin and a diagnostic test for Alzheimer’s Disease.
Sector
Discretionary
Industry
Leisure & Recreation Services